Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Resources for Patients, Survivors, Providers, Researchers, and Supporters

TON - December 2013 Vol 6 No 11 published on December 20, 2013 in Gynecologic Cancers
Peg Ford

Ovarian Cancer Alliance of San Diego
www.ocaofsd.org
Peg Ford, Cancer Research Advocate, Founder/Chair
The Alliance strives to affect change in the way medical doctors consider the diagnosis and treatment of ovarian cancer; educate the medical community, patient organizations, and the community at large about early diagnosis; further research on evidence-based treatment options; and, ultimately, eradicate the disease.

The Clearity Foundation
www.clearityfoundation.org

The Foundation helps patients with ovarian cancer and their physicians in making better-informed treatment decisions based on the molecular profile of the tumor (the “tumor blueprint”), thus enabling a more individualized approach to therapy selection. Patient support services include lab test coordination, tumor blueprint interpretation, and clinical trial identification free of charge.

FORCE (Facing Our Risk of Cancer Empowered)
www.facingourrisk.org

FORCE is a national nonprofit agency dedicated to improving the lives of individuals and families affected by hereditary breast and ovarian cancer. Information on cancer management and treatment, clinical trials and research, support, advocacy, and events is offered on the website. A toll-free helpline can be reached at 1-866-288-RISK.

Foundation for Women’s Cancer
www.foundationforwomenscancer.org

The Foundation offers many awareness, educational, and fundraising programs as well as comprehensive information about gynecologic cancer risk prevention, early detection, and optimal treatments provided by gynecologic oncologists and other healthcare experts.

Guidelines International Network (G-I-N)
www.g-i-n.net

G-I-N offers partnership opportunities for guideline organizations, assists in improving the efficiency and effectiveness of healthcare guideline development, and promotes best practices through opportunities for learning and the establishment of standards. G-I-N/North America provides a community for North American guideline users, developers, and other stakeholders to form partnerships and discuss regional guideline issues.

National Ovarian Cancer Coalition (NOCC)
www.ovarian.org

The Coalition is committed to improving the survival rate and quality of life for women with ovarian cancer. Through national programs and local chapter initiatives, NOCC’s goal is to make more people aware of the early symptoms of the disease. In addition, NOCC provides information to assist the newly diagnosed patient as well as hope and support to survivors and caregivers.

Ovarian Cancer National Alliance
www.ovariancancer.org

The Alliance advocates at a national level for increases in research funding for the development of an early detection test, improved healthcare practices, and life-saving treatment protocols. The Ovarian Cancer Symptom Diary App (www.ovariancancer.org/app) helps individuals learn about the risks, signs, and symptoms of the disease. This first-of-its-kind application allows a woman to track symptoms that could indicate ovarian cancer, and alerts her if she should make an appointment with her doctor for further testing.

Ovarian Cancer Research Fund
www.ocrf.org

The Ovarian Cancer Research Fund is the oldest and largest philanthropic organization in the United States funding ovarian cancer research. Through its auspices, more than $50 million has been granted to the most innovative and promising ovarian cancer research.

Patient Advocate Foundation (PAF)
www.patientadvocate.org/myresources

PAF advocates and mediates on behalf of patients to provide access to evolving therapies, therapeutic agents, and devices. Professional patient assistance is offered by telephone, email, or live web chat. PAF’s free My Resource Search app is an easy-to-use tool for healthcare, financial, and insurance help that allows both insured and uninsured patients to identify the community and national programs that can assist in their healthcare needs.

Society of Gynecologic Oncology (SGO)
www.sgo.org

With more than 1700 domestic and international members, SGO is the premier medical specialty society for healthcare professionals trained in the comprehensive management of gynecologic cancers. SGO contributes to the advancement of women’s cancer care by promoting research, providing education, raising standards of practice, advocating for patients and members, and collaborating with other national and global organizations.

Related Items
Encourage Minority Patients with Ovarian Cancer to Participate in Clinical Trials
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Gynecologic Cancers
Global Commitment to Impact Evidence-Based Healthcare
Peg Ford
TON - November/December 2014 Vol 7 No 6 published on January 7, 2015
Pelvic Exam Not Needed for All Women?
Peg Ford
TON - September/October 2014 Vol 7 No 5 published on November 4, 2014
The New Bold Frontier of the “War on Cancer”
Peg Ford
TON - May/June 2014 Vol 7 No 3 published on July 14, 2014
In a Perfect World of Scientific Conferences: Less Stress, Less Strain!
Peg Ford
TON - March/April 2014 Vol 7 No 2 published on April 10, 2014
Antiangiogenesis Pursued in High-Risk Ovarian Cancer
Alice Goodman
TON - December 2013 Vol 6 No 11 published on December 20, 2013 in Gynecologic Cancers
Neoadjuvant Chemotherapy a Reasonable Option for Advanced Ovarian Cancer
Alice Goodman
TON - December 2013 Vol 6 No 11 published on December 20, 2013 in Gynecologic Cancers
Important Steps in the Conquest of Ovarian Cancer
Peg Ford
TON - December 2013 Vol 6 No 11 published on December 20, 2013
Pazopanib: First Positive Maintenance Trial
Phoebe Starr
TON - December 2013 Vol 6 No 11 published on December 20, 2013 in Gynecologic Cancers
Project LEAD: An Innovative Science Program for Advocates
Peg Ford
TON - October 2013 Vol 6 No 9 published on October 30, 2013
Last modified: September 9, 2019